Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats

Gut

Volumn 55, Issue 11, 2006, Pages 1606-1616

  Ebrahimkhani, M R ^a,b   Kiani, S ^b   Oakley, F ^b   Kendall, T ^b   Shariftabrizi, A ^b   Tavangar, S M ^c   Moezi, L ^b   Payabvash, S ^b   Karoon, A ^b   Hoseininik, H ^b   Mann, D A ^b   Moore, K P ^a   Mani, A R ^a   Dehpour, A R ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD45 ANTIGEN; GELATINASE A; GLUTATHIONE; HYDROXYPROLINE; NALTREXONE; NITRIC OXIDE; OPIATE ANTAGONIST; OPIATE RECEPTOR; PROCOLLAGEN; S NITROSOTHIOL; SIGMA OPIATE RECEPTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CELL PROLIFERATION; DRUG EFFECT; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER FIBROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ZYMOGRAPHY;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN TYPE I; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; MATRIX METALLOPROTEINASE 2; NALTREXONE; NARCOTIC ANTAGONISTS; NITRIC OXIDE; OXIDATION-REDUCTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 33750377555     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.076778     Document Type: Article

References (44)

1. Thornton JR, Losowsky MS. Opioid peptides and primary biliary cirrhosis. BMJ 1988;297:1501-4.
2. Gaskari SA, Mani AK, Ejtemaei-Mehr S, et al. Do endogenous opioids contribute to the brodycardia of rats with obstructive cholestasis? Fundam Clin Pharmacol 2002;16:273-9.
3. Kiani S, Ebrahimkhani MR, Shariftabrizi A, et al. Opioid system blockade decreases collogenase activity and improves liver injury in a rat model of cholestasis. J Gastroenterol Hepatol (in press).
4. Ebrohimkhani MR, Payabvash S, Mani AR, et al. Cholestasis and systemic oxidative stress: role of endogenous opioids. J Hepatol 2004;40:51S.
5. Roberts SM, Skoulis NP, James RC. A centrally-mediated effect of morphine to diminish hepatocellular gkitathione. Biochem Pharmacol 1987;36:3001-5.
6. Zhang YT, Zheng QS, Pan J, et al. Oxidative damage of biomolecules in mouse liver induced by morphine and protected by antioxidants. Basic Clin Pharmacol Toxicol 2004;95:53-8.
7. Campbell SJ, Hughes PM, Iredale JP, et al. CINC-1 is an acute-phase protein induced by focal brain injury causing leukocyte mobilization and liver injury. FASB J 2003;17:1168-70.
8. Benyon RC, Arthur MJ. Extracellular matrix degradation and the role of hepatic stellate cells. Semin Liver Dis 2001;21:373-84.
9. Gu Z, Kaul M, Yan B, et al. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 2002;297:1186-90.
10. Tyagi SC, Kumar S, Borders S. Reduction-oxidation (redox) state regulation of extracellular matrix metalloproteinases and tissue inhibitors in cardiac normal and transformed fibroblast cells. J Cell Biochem 1996;61:139-51.
11. Okamoto T, Akaike T, Sawa T, et al. Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation. J Biol Chem 2001;276:29596-602.
12. Jamall IS, Finelli VN, Hee SS. A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues. Anal Biochem, 1981;112, 70-5.
13. Kossakowska AE, Edwards DR, Lee SS, et al. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis. Am J Pathol 1998;153:1895-902.
14. Moore KP, Mani AR. Measurement of protein nitration and S-nitrosothiol formation in biology and medicine. Methods Enzymol 2002;359:256-68.
15. Fernando B, Marley R, Holt S, et al. N-acetylcysteine prevents development of the hyperdynamic circulation in the portal hypertensive rat. Hepatology 1998;28:689-94.
16. Wittert G, Hope P, Pyle D. Tissue distribution of opioid receptor gene expression in the rat. Biochem Biophys Res Commun 1996;218:877-81.
17. Trim JE, Samra SK, Arthur MJ, et al. Upstream tissue inhibitor of metalloproteinases-1 (TIMP-1) element-1, a novel and essential regulatory DNA motif in the human TIMP-1 gene promoter, directly interacts with a 30-kDa nuclear protein. J Biol Chem 2000;275:2257-63.
18. Iuvone T, Capasso A, D'Acquisto F, et al. Opioids inhibit the induction of nitric oxide synthesis in J774 macrophages. Biochem Biophys Res Commun 1995;212:975-80.
19. Kampa M, Hatzoglou A, Notas G, et al. Opioids are non-competitive inhibitors of NOS in T47D human breast cancer cells. Cell Death Differ 2001;8:943-52.
20. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991;13:372-4.
21. Miyoshi H, Rust C, Roberts PJ, et al. Hepatocyle apoptosis after bile duct ligation in the mouse involves Fas. Gastroenterology 1999;117:669-77.
22. Oakley F, Meso M, Iredale JP, et al. Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis. Gastroenterology 2005;128:108-20.
23. Mason DY, Gatter KC. The role of immunocytochemistry in diagnostic pathology. J Clin Pathol 1987;40:1042-54.
24. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-9.
25. Stefano GB, Hartman A, Bilfinger TV, et al. Presence of the mu3 opiate receptor in endothelial cells. Coupling to nitric oxide production and vasodilation. J Biol Chem 1995;270:30290-3.
26. Yurdaydin C, Karavelioglu D, Onaran O, et al. Opioid receptor ligands in human hepatic encephalopathy. J Hepatol 1998;29:796-801.
27. Bergasa NV, Talbot TL, Ailing DW, et al. A controlled trial of naloxone infusions for the pruritus of chronic cholestasis. Gastroenterology 1992;102:544-9.
28. Joume M, Jacquet S, Cavailles P, et al. Opioid receptor blockade reduces Fas-induced hepatitis in mice. Hepatology 2004;40:1136-43.
29. Agarwal D, Glasel JA. Differential effects of opioid and adrenergic agonists on proliferation in a cultured cell line. Cell Prolif 1999;32:215-29.
30. Leslie FM, Chen Y, Winzer-Serhan UH. Opioid receptor and peptide mRNA expression in proliferative zones of fetal rat central nervous system. Can J Physiol Pharmacol 1998;76:284-93.
31. Law PY, McGinn TM, Campbell KM, et al. Agonist activation of δ-opioid receptor but not μ-opioid receptor potentiates fetal calf serum or tyrosine kinase receptor-mediated cell proliferation in a cell-line-specific manner. Mol Pharmacol 1997;51:152-60.
32. Benyon RC, Iredale JP, Goddard S, et al. Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver. Gastroenterology 1996;110:821-31.
33. Kasahara A, Hayashi N, Mochizuki K, et al. Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C. Relationship to Interferon response. J Hepatol 1997;26:574-83.
34. Yoshiji H, Kuriyama S, Yoshii J, et al. Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse. Hepatology 2002;36:850-60.
35. Ljubuncic P, Tanne Z, Bomzon A. Evidence of a systemic phenomenon for oxidative stress in cholestatic liver disease. Gut 2000;47:710-16.
36. Ottesen LH, Harry D, Frost M, et al. Increased formation of S-nitrothiols and nitrotyrosine in cirrhotic rats during endotoxemia. Free Radic Biol Med 2001;31:790-8.
37. Toledano MB, Leonard WJ. Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proc Natl Acad Sci U S A 1991;88:4328-32.
38. Marshall HE, Hess DT, Stamler JS. S-nitrosytation: physiological regulation of NF-kappaB. Proc Natl Acad Sci U S A 2004;101:8841-2.
39. Hess DT, Matsumoto A, Kim SO, et al. Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol 2005;6:150-06.
40. Jones DP, Carlson JL, Mody VC, et al. Redox state of glutathione in human plasma. Free Radic Biol Med 2000;28:625-35.
41. Burk HF. Glutathione-dependent protection by rat liver microsomal protein against lipid peroxidation. Biochim Biophys Acta 1983;757:21-8.
42. Jaeschke H, Smith CV, Mitchell JR. Reactive oxygen species during ischemia-reflow injury in isolated perfused rat liver. J Clin Invest 1988;81:1240-6.
43. Moellaro E, Casini AF, Del Belb B, et al. Lipid peroxidation and antioxidant systems in the liver injury produced by glutathione depleting agents. Biochem Pharmacol 1990;39:1513-21.
44. Li Y, Zhang T, Douglas SD, et al. Morphine enhances hepatitis C virus (HCV) replicon expression. Am J Pathol 2003;163:1167-75.